BlackRock

Apollo Global

Lenders to Altice USA File Motion to Dismiss Antitrust Lawsuit

Apollo Global shares surge 5.63% after-hours as valuation models suggest significant undervaluation and strong Q3 performance fuels optimism.

Apollo Global shares rise 5.42% intraday as Q4 earnings, BGH Pharma funding, and AI/logistics investments drive optimism.

阿波罗全球管理

Apollo Global's 15min chart signals MACD death cross, narrowing Bollinger Bands

Catalyst<ul> <li>Most analysts rate APO Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Bearish signals are obviously dominant (3 bearish vs 0 bullish) according to technical indicators.</li> <li>Fund flows show negative trends across all order sizes, indicating investor withdrawal.</li> <li>Market expectations tend to be pessimistic despite mixed analyst ratings.</li></ul>

Key Factors

Apollo Global (APO) closed with a 5.51% increase on February 6, 2026, despite a 181st-ranked trading volume of $0.81 billion and ongoing legal scrutiny over past ties to Jeffrey Epstein.APO is scheduled to report Q4 2025 earnings on February 9, with analysts expecting declining earnings per share but higher revenues compared to the prior year.Apollo Global shares surged 5.63% in after-hours trading after joining Goldman Sachs and Blackstone in backing a $1.4 billion loan for BGH Capital's acquisition, signaling strong institutional support.APO's stock fell 5.06% on February 5, closing at $126.08 amid a bearish engulfing pattern and a potential death cross, reflecting deepening technical bearish signals and legal concerns.Apollo Global's shares rose 5.29% intraday following analyst upgrades and strategic investments in AI, logistics, and renewable energy, including a $6.5 billion investment in Ørsted's UK wind farm.

APO News